Successful Rechallenge With Reduced Dose of Erlotinib in a Patient With Lung Adenocarcinoma Who Developed Erlotinib‑associated Leukocytoclastic Vasculitis: A Case Report

Oncology Letters - Greece
doi 10.3892/ol.2012.647
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications


Related search